You are here: Home Experience Mergers and Buy-side União Química

União Química

Date February, 2015
Client União Química
Counterparty Novartis
Industry Pharmaceutical
Amount Not disclosed

Landmark Capital acted as exclusive financial advisor of União Química Farmacêutica Nacional, one of Brazil´s leading pharmaceutical company, in the structuring and negotiation of a long term manufacture agreement of Novartis medicines, one of world´s largest pharmaceutical company, at Taboão da Serra/SP facility. This plant manufactures medicines to supply the Latin American market.

Besides the manufacturing agreement, the transaction also included the acquisition of Taboão da Serra/SP facility by União Química.